Page 37 - Haematologica-5
P. 37

TCR repertoire of effector memory T cells in AA
1: a candidate autoantigen in acquired aplas- tic anemia patients harboring a minor popu- latoin of paroxysmal nocturnal hemoglobin- uria-type cells. Blood. 2004; 104:(8)2425- 2431.
15. Kook H, Risitano AM, Zeng W, et al. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. Blood. 2002;99(10):3668-3675.
16. Clemente MJ, Wlodarski MW, Makishima H, et al. Clonal drift demonstrates unexpect- ed dynamics of the T-cell repertoire in T- large granular lymphocyte leukemia. Blood. 2011;118(16):4384-4393.
17. Clemente MJ, Przychodzen B, Jerez A, et al. Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lympho- cyte leukemia identifies signature land- scapes. Blood. 2013;122(25):4077-4085.
18. Calis JJ, Rosenberg BR. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends Immunol. 2014;35(12):581-590.
19. Langerak AW, van Den Beemd R, Wolvers- Tettero IL, et al. Molecular and flow cyto- metric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations. Blood. 2001;98(1):165-173.
20. Wlodarski MW, Gondek LP, Nearman ZP, et al. Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodys- plastic syndrome. Blood. 2006;108(8):2632- 2641.
21. Schuster FR, Hubner B, Führer M, et al. Highly skewed T-cell receptor V-beta chain repertoire in the bone marrow is associated with response to immunosuppressive drug therapy in children with very severe aplastic anemia. Blood Cancer J. 2011;1(3):e8.
22. Schatz DG, Ji Y. Recombination centres and the orchestration of V(D)J recombination. Nat. Rev. Immunol. 2011;11:(4)251-263.
23. Gauss GH, Lieber MR. Mechanistic con- straints on diversity in human V(D)J recom- bination. Mol Cell Biol. 1996;16(1):258-269.
24. Teng G, Papavasiliou FN. Immunoglobulin somatic hypermutation. Annu Rev Genet. 2007;41:107-120.
25. Matthews AJ, Zheng S, DiMenna LJ, Chaudhuri J. Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair.
Adv Immunol. 2014;122:1-57. lic T cell responses. Cell Res. 2012;22(1):33- 26. Arstila TP, Casrouge A, Baron V, Even J, 42.
Kanellopoulos J, Kourilsky P. A direct esti- 40. Gargiulo L, Lastraioli S, Cerruti G, et al. mate of the human alphabeta T cell receptor Highly homologous T-cell receptor beta diversity. Science. 1999;286(5441):958-961. sequences support a common target for
27. Bretschneider I, Clemente MJ, Meisel C, et autoreactive T cells in most patients with al. Discrimination of T-cell subsets and T- paroxysmal nocturnal hemoglobinuria. cell receptor repertoire distribution. Blood. 2007;109(11):5036-5042.
Immunol Res. 2014;58(1):20-27. 41. Risitano AM, Kook H, Zeng W, Chen G,
28. Araki K, Youngblood B, Ahmed R. The role Young NS, Maciejewski JP. Oligoclonal and of mTOR in memory CD8 T-cell differenti- polyclonal CD4 and CD8 lymphocytes in ation. Immunol Rev. 2010;235(1):234-243. aplastic anemia and paroxysmal nocturnal
29. Appay V, van Lier RA, Sallusto F, Roederer hemoglobinuria measured by V beta CDR3 M. Phenotype and function of human T spectratyping and flow cytometry. Blood. lymphocyte subsets: consensus and issues. 2002;100(1):178-183.
Cytometry A. 2008;73(11):975-983. 42. Filaci G, Fenoglio D, Fravega M et al. CD8+
30. Farber DL, Yudanin NA, Restifo NP. Human CD28- T regulatory lymphocytes inhibiting memory T cells: generation, compartmen- T cell proliferative and cytotoxic functions talization and homeostasis. Nat Rev infiltrate human cancers. J Immunol 2007; Immunol. 2014;14(1):24-35. 179:(7)4323-4334.
31. World Medical Association. World Medical 43. Characiejus D, Pasukoniene V, Association Declaration of Helsinki: ethical Jonusauskaite R, et al. Peripheral blood principles for medical research involving CD8high CD57+ lymphocyte levels may human subjects. JAMA. 2013;310(20):2191- predict outcome in melanoma patients treat- 2194. ed with adjuvant interferon-alpha.
32. International Agranulocytosis and Aplastic Anticancer Res. 2008;28:(2B)1139-1142. Anaemia Study. Incidence of aplastic ane- 44. Kook H, Zeng W, Guibin C, Kirby M, Young mia: the relevance of diagnostic criteria. By NS, Maciejewski JP. Increased cytotoxic T the International Agranulocytosis and cells with effector phenotype in aplastic ane- Aplastic Anemia Study. Blood. mia and myelodysplasia. Exp Hematol. 1987;70(6):1718-1721. 2001;29:(11)1270-1277.
33. Camitta BM, Thomas ED, Nathan DG, et al. 45. Boucher N, Dufeu-Duchesne T, Vicaut E, Severe aplastic anemia: a prospective study Farge D, Effros RB, Schächter F. CD28 of the effect of early marrow transplantation expression in T cell aging and human on acute mortality. Blood. 1976;48(1):63-70. longevity. Exp Gerontol. 1998;33(3):267-
34. Bolotin DA, Shugay M, Mamedov IZ, et al. 282.
MiTCR: software for T-cell receptor 46. Wikby A, Ferguson F, Forsey R, et al. An sequencing data analysis. Nat Methods. immune risk phenotype, cognitive impair- 2013;10(9):813-814. ment, and survival in very late life: impact of
35. Benjamini Y, Yekutieli D. The control of the allostatic load in Swedish octogenarian and false discovery rate in multiple testing under nonagenarian humans. J Gerontol A Biol Sci dependency. Ann Stat. 2001; 29:(4)1165- Med Sci. 2005;60(5):556-565.
1188. 47. Fozza C, Barraqueddu F, Corda G, et al.
36. Strioga M, Pasukoniene V, Characiejus D. Study of the T-cell receptor repertoire by CD8+ CD28- and CD8+ CD57+ T cells and CDR3 spectratyping. J Immunol Methods. their role in health and disease. 2017;440:1-11.
Immunology. 2011;134(1):17-32. 48. Zeng W, Maciejewski JP, Chen G, Young NS.
37. Nickel RS, Horan JT, Fasano RM, et al. Limited heterogeneity of T cell receptor BV Immunophenotypic parameters and RBC usage in aplastic anemia. J Clin Invest. alloimmunization in children with sickle cell 2001;108(5):765-773.
disease on chronic transfusion. Am J 49. Le Gal FA, Ayyoub M, Dutoit V, et al. Hematol. 2015;90(12):1135-1141. Distinct structural TCR repertoires in natu-
38. Hill MO. Diversity and evenness: a unifying rally occurring versus vaccine-induced notation and its consequences. Ecology. CD8+ T-cell responses to the tumor-specific 1973;54:(2)427-432. antigen NY-ESO-1. J Immunother.
39. Li H, Ye C, Ji G, Han J. Determinants of pub- 2005;28(3):252-257.
haematologica | 2018; 103(5)
769


































































































   35   36   37   38   39